Hinge Health, Inc. (HNGE) Quick Ratio
- Quick ratio · latest quarter: Value 1.07×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.07× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $514.82M ÷ $481.44M ≈ 1.07× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 514.82M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 481.44M USD | Liabilities, Current |
| Cash and equivalents | 286.22M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 103.17M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | 125.43M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 16.77M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $514.82M | $481.44M | $286.22M | $103.17M | $125.43M | $16.77M | 1.07× |
| 2026-03-31 | $430.79M | $414.48M | $186.67M | $129.20M | $114.92M | $14.17M | 1.04× |
| 2025-12-31 | $429.92M | $362.41M | $208.00M | $155.87M | $66.06M | $15.64M | 1.19× |
| 2025-09-30 | $566.79M | $357.08M | $261.34M | $218.69M | $86.77M | $13.81M | 1.59× |
| 2025-06-30 | $512.56M | $314.08M | $237.17M | $176.09M | $99.30M | $13.99M | 1.63× |
| 2025-03-31 | (m) | (m) | $288.48M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $509.07M | $249.30M | $300.79M | $165.79M | $42.49M | $10.87M | 2.04× |
| 2024-09-30 | (m) | (m) | $267.53M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $236.63M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $234.95M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.